Source: Annual Congress 2001 - Infection in the ICU
Disease area: Respiratory critical care, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
V. Dudzevicius, R. Sakalauskas, I. Stankeviciene, K. Malakauskas (Kaunas, Lithuania). Common pathogens in bronchial secretions of the ICU patients with nosocomial pneumonia. Eur Respir J 2001; 16: Suppl. 31, 2753

Member's Comments

No comment yet.

Related content which might interest you: Nosocomial tracheobronchitis in mechanically ventilated patients: incidence, aetiology and outcome Source: Eur Respir J 2002; 20: 1483-1489 Year: 2002 The lung bacterial microbiome in community-acquired and nosocomial pneumonia Source: Eur Respir Monogr 2019; 83: 188-194 Year: 2019 Prevention of nosocomial infections in acute respiratory failure patients Source: Eur Respir J 2003; 22: 72S-76S Year: 2003 Prevalence of atypical bacterial pathogens in hospitalized patients with community-acquired pneumonia Source: Annual Congress 2013 –Difficult and rare respiratory infections Year: 2013 Respiratory infections in the immunocompetent host: from asthma exacerbations to hospital-acquired pneumonia Source: Annual Congress 2007 - Infections year in review Year: 2007 BAL and microbiological surveillance of nosocomial pneumonia in ARDS patients Source: Eur Respir J 2006; 28: Suppl. 50, 786s Year: 2006 The comparison of hospitalized healthcare-associated pneumonia with community-acquired pneumonia patients Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients Year: 2010 Impact of candida spp. colonization of respiratory tract in patients with intensive care unit-acquired pneumonia Source: Annual Congress 2013 –Difficult and rare respiratory infections Year: 2013 Diagnosis and treatment of nosocomial pneumonia in ALI/ARDS patients Source: Eur Respir J 2003; 22: 77S-83S Year: 2003 Carbapenem-resistant pathogens in US patients hospitalized with respiratory infections Source: International Congress 2018 – Clinical challenges in respiratory infection Year: 2018 Impact of nosocomial pneumonia on the outcome of mechanically-ventilated patients Source: Eur Respir J 2004; 24: Suppl. 48, 548s Year: 2004 Risk factors for drug-resistant pathogens in patients with hospital-acquired and ventilator-associated pneumonia Source: International Congress 2017 – Respiratory infections in critically ill and immuno-depressed patientes Year: 2017 Impact of aspiration pneumonia in community-acquired pneumonia and healthcare-associated pneumonia Source: Annual Congress 2012 - CT findings: educational posters Year: 2012 Comparison of clinical characteristics between healthcare-associated pneumonia and community-acquired pneumonia in patients admitted into secondary hospitals Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections Year: 2012 Lower respiratory tract infections: when are antibiotics mandatory? Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=146 Year: 2004 Ventilator-associated pneumonia (VAP) pathogenic microorganisms eradication and persistence during antimicrobial therapy Source: Annual Congress 2013 –Recent developments in pneumonia Year: 2013 Fluoroquinolones and lower respiratory tract infections Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=94 Year: 2004 Comparison of costs of community-acquired pneumonia (CAP) treatment at patients with and without bronchial obstruction Source: Annual Congress 2011 - COPD management Year: 2011 Cardiovascular consequences of community-acquired pneumonia and other pulmonary infections Source: Eur Respir Monogr 2020; 88: 212-228 Year: 2020